Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 04-2011 | 01-2011 | 10-2010 | 07-2010 | 04-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127 | 280 | 63 | 431 | 416 |
| Receivables | 170 | 176 | 75 | 57 | 20 |
| TOTAL | $304 | $464 | $140 | $493 | $443 |
| Non-Current Assets | |||||
| PPE Net | 3,210 | 3,252 | 3,138 | 2,925 | 2,896 |
| TOTAL | $3,210 | $3,252 | $3,138 | $2,925 | $2,896 |
| Total Assets | $3,513 | $3,717 | $3,278 | $3,418 | $3,339 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 878 | 804 | 910 | 822 | 847 |
| Accounts payable and accrued liabilities | 101 | 167 | N/A | N/A | N/A |
| TOTAL | $981 | $973 | $1,050 | $1,138 | $1,090 |
| Non-Current Liabilities | |||||
| Long Term Debt | 599 | 676 | 75 | 75 | 75 |
| TOTAL | $599 | $676 | $75 | $75 | $75 |
| Total Liabilities | $1,580 | $1,649 | $1,125 | $1,213 | $1,165 |
| Shareholders' Equity | |||||
| Common Shares | 13 | 13 | 13 | 13 | 12 |
| Retained earnings | -4,210 | -4,055 | -3,924 | -3,847 | -3,817 |
| TOTAL | $1,933 | $2,068 | $2,154 | $2,205 | $2,175 |
| Total Liabilities And Equity | $3,513 | $3,717 | $3,278 | $3,418 | $3,339 |